Top Markets
Coin of the day
Lansen Pharmaceutical Holdings Limited Lansen Pharmaceutical Holdings Limited

Lansen Pharmaceutical Holdings Limited

0503
Rank in Stocks #22050
Lansen Pharmaceutical Holdings Limited, an investment holding company,... Lansen Pharmaceutical Holdings Limited, an investment holding company, concentrates on the research, manufacturing, and global distribution of niche pharmaceutical drugs. These specialized medicines primarily address conditions in rheumatology and dermatology, serving both the People's Republic of China and international markets. The company's business operations are organized into three distinct divisions: Pharmaceuticals, Cosmetic Products, and Healthcare Products. Its product range includes generic traditional Chinese medicines, various cosmetic goods, and health-related items. Established in 2001, its main offices are situated in Ningbo, China. Lansen Pharmaceutical Holdings Limited operates as a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Share Price
$0.22961818
Last synced: 2023-12-18
Market Cap
$95.29M
Change (1 day)
0.16%
Change (1 year)
0.00%
Country
CN
Trade Lansen Pharmaceutical Holdings Limited (0503)

Category

P/B ratio for Lansen Pharmaceutical Holdings Limited (0503)
P/B ratio as of 2026 TTM: 0
According to Lansen Pharmaceutical Holdings Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Lansen Pharmaceutical Holdings Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors